Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 2
2008 2
2009 4
2010 3
2011 5
2012 5
2013 8
2014 6
2015 4
2016 5
2017 3
2018 3
2019 4
2020 7
2021 6
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis.
Degiacomi G, Gianibbi B, Recchia D, Stelitano G, Truglio GI, Marra P, Stamilla A, Makarov V, Chiarelli LR, Manetti F, Pasca MR. Degiacomi G, et al. Among authors: pasca mr. ACS Omega. 2023 Jul 3;8(28):25209-25220. doi: 10.1021/acsomega.3c02311. eCollection 2023 Jul 18. ACS Omega. 2023. PMID: 37483251 Free PMC article.
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium.
van Wijk RC, Lucía A, Sudhakar PK, Sonnenkalb L, Gaudin C, Hoffmann E, Dremierre B, Aguilar-Ayala DA, Molin MD, Rybniker J, de Giorgi S, Cioetto-Mazzabò L, Segafreddo G, Manganelli R, Degiacomi G, Recchia D, Pasca MR, Simonsson USH, Ramón-García S; ERA4TB consortium. van Wijk RC, et al. Among authors: pasca mr. iScience. 2023 Mar 15;26(4):106411. doi: 10.1016/j.isci.2023.106411. eCollection 2023 Apr 21. iScience. 2023. PMID: 37091238 Free PMC article.
New Drugs and Novel Cellular Targets against Tuberculosis.
Degiacomi G, Makarov V, Pasca MR, Chiarelli LR. Degiacomi G, et al. Among authors: pasca mr. Int J Mol Sci. 2022 Nov 8;23(22):13680. doi: 10.3390/ijms232213680. Int J Mol Sci. 2022. PMID: 36430162 Free PMC article.
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization.
Girardini M, Ferlenghi F, Annunziato G, Degiacomi G, Papotti B, Marchi C, Sammartino JC, Rasheed SS, Contini A, Pasca MR, Vacondio F, Evans JC, Dick T, Müller R, Costantino G, Pieroni M. Girardini M, et al. Among authors: pasca mr. Eur J Med Chem. 2023 Jan 5;245(Pt 2):114916. doi: 10.1016/j.ejmech.2022.114916. Epub 2022 Nov 11. Eur J Med Chem. 2023. PMID: 36399878 Free PMC article.
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis.
Salina EG, Postiglione U, Chiarelli LR, Recchia D, Záhorszká M, Lepioshkin A, Monakhova N, Pál A, Porta A, Zanoni G, Korduláková J, Kazakova E, Sassera D, Pasca MR, Makarov V, Degiacomi G. Salina EG, et al. Among authors: pasca mr. mSphere. 2022 Dec 21;7(6):e0036922. doi: 10.1128/msphere.00369-22. Epub 2022 Nov 15. mSphere. 2022. PMID: 36377880 Free PMC article.
Editorial: New Approaches Against Drug-Resistant M. tuberculosis.
Av-Gay Y, Mori G, Pasca MR. Av-Gay Y, et al. Among authors: pasca mr. Front Microbiol. 2021 Apr 15;12:681420. doi: 10.3389/fmicb.2021.681420. eCollection 2021. Front Microbiol. 2021. PMID: 33936024 Free PMC article. No abstract available.
68 results